Molefy Pharma
PrivateLast Round
Grant
Oct 7, 2025
Total Funding Raised
$1.18M
Momentum Score
50 /100
Company Overview
Molefy Pharma is a biotechnology company developing treatments for neurodegenerative diseases, with a focus on Amyotrophic Lateral Sclerosis (ALS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molefy Pharma Comps
Public and private peers based on sector, stage, and business model.
Molefy Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2025 | ||||
| Grant | Mar 20, 2023 |
Molefy Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| The Association for Frontotemporal Degeneration | Grant |
| Consejo Superior de Investigaciones Científicas | Corporate Funding |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2025
$1M grant from The ALS Association
- Mar 20, 2023
$184K grant from Alzheimer's Drug Discovery Foundation.
Molefy Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Molefy Pharma's valuation, stock price, and market status.
